Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to develop imaging techniques to determine the density of blood vessels and the amount of blood flow in Kaposi s sarcoma (KS) tumors. KS tumors depend on the formation of new blood vessels for their growth. Some experimental therapies for KS are directed at reducing the amount of blood vessels and blood flow in these lesions. Measurement of blood vessel density and blood flow in these lesions could be useful in evaluating the effectiveness of both standard and experimental treatments for this disease.

Patients 18 years of age or older with Kaposi's sarcoma involving the skin may be eligible for this study. Participants will have photographs taken of their lesions and will undergo three imaging procedures (described below) at the beginning of the study (baseline) and then about once every 3 months or so while on the study (up to 2 years) to compare the test results over time. (Imaging may be done at more or less frequent intervals depending on the findings.) A small amount of blood (less than a tablespoon) will be drawn the day of each imaging procedure.

Laser Doppler imaging This technique measures the amount of blood flow in KS lesions by scanning the lesions with a low-power laser beam. Each lesion takes about 3 minutes to scan. The imaging may be done before and after a blood pressure cuff around the arm is inflated for a short time (usually less than 30 seconds).

Multi-spectral imaging This technique uses light to measure the total blood volume in each lesion and how much oxygen is in the blood. Oxygen is carried to the body s cells by a protein in red blood cells called hemoglobin. The light on the multi-spectral imaging instrument is absorbed differently depending on whether the hemoglobin has oxygen attached to it or not. It takes about 2 minutes to scan each lesion.

Infrared thermal imaging This test uses a special camera to take digital infrared pictures of the skin. Images formed of the temperature of the KS lesions are used to assess blood flow in the lesions. This imaging takes about 1 minute per lesion.

...


Clinical Trial Description

Background:

Kaposi's sarcoma is a highly vascular tumor. As such, it may provide a good model for the study of angiogenesis-based therapy in cancer. However, there are no standardized techniques now available to assess the effects of anti-angiogenesis therapy on blood flow in KS tissues. The present protocol was written to allow us to explore and gain experience with four promising techniques to examine tumor vasculature in cutaneous KS lesions: a) laser Doppler imaging; b) multi-spectral imaging; c) infrared thermal imaging; and d) optical coherence tomography.

Objectives:

The main objective is to assess, in preliminary fashion, non-invasive methods for studying tumor vascularity and vascular changes in patients with Kaposi's sarcoma using four different imaging techniques. Other objectives are to correlate these techniques to each other and to conventional KS tumor assessment, and to assess the response of these techniques in patients receiving therapy for Kaposi s sarcoma.

Eligibility:

Patients 18 of more years of age with biopsy-proven cutaneous Kaposi's sarcoma involving the skin or mucosa are eligible. They must be willing and able to give informed consent.

Design:

This will be a preliminary study to explore these techniques in Kaposi's sarcoma. Selected Kaposi's sarcoma lesions of patients will be assessed using laser Doppler imaging, multi-spectral imaging, infrared thermal imaging, and optical coherence tomography at entry and then additional time points for up to 4 years. Lesions will also be assessed by conventional measurement and photographs with conventional cameras. In selected patients in which there are Kaposi's sarcoma lesions on the arm, the effects of stopping venous flow for up to 10 seconds will be assessed on the measurements. A complete blood count will be done the day of the measurements. The results of the imaging techniques will be compared with each other, and with conventional tumor assessments. Changes over time will be assessed. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT00026793
Study type Observational
Source National Institutes of Health Clinical Center (CC)
Contact
Status Completed
Phase
Start date April 23, 2001
Completion date December 20, 2017

See also
  Status Clinical Trial Phase
Completed NCT02201420 - Evaluation of Technetium Tc 99m Tilmanocept (Lymphoseek®) Localization, Retention, and Distribution in Primary Cutaneous Kaposi's Sarcoma (KS) and Lymphatic Drainage From KS Lesions by SPECT and SPECT/CT Imaging Phase 2
Terminated NCT00686842 - PTC299 in Treating Patients With HIV-Related Kaposi Sarcoma Phase 1/Phase 2
Completed NCT00339326 - Risk Factors for Non-HIV-Related Kaposi s Sarcoma
Completed NCT01352117 - Antiretroviral Therapy (ART) Alone or With Delayed Chemo Versus ART With Immediate Chemo for Limited AIDS-related Kaposi's Sarcoma Phase 3
Completed NCT01276236 - Effects of Maraviroc (MVC) on HIV-related Kaposi's Sarcoma (KS) Phase 2
Completed NCT00001535 - Twins Study of Gene Therapy for HIV Infection Phase 1
Completed NCT01067690 - Treatment With Indinavir and Chemotherapy for Advanced Classical Kaposi's Sarcoma Phase 2
Completed NCT00540566 - Optical Biopsy of Human Skin in Conjunction With Laser Treatment
Completed NCT00380770 - HIV/AIDS Kaposis Sarcoma: Comparison of Response to HAART vs HAART Plus CXT Phase 4
Completed NCT00001294 - Genetic Factors and Interrelationships for Sexual Orientation, Susceptibility to HIV and Kaposi's Sarcoma, Alcoholism and Psychological Traits, and Histocompatibility Antigens N/A
Completed NCT00055237 - Bevacizumab to Treat Kaposi's Sarcoma in HIV-Positive and HIV-Negative Patients Phase 2
Completed NCT00026728 - Seroprevalence of Kaposi's Sarcoma Herpes Virus in the United States N/A
Terminated NCT00287495 - BAY 43-9006 (Sorafenib) to Treat Patients With Kaposi's Sarcoma Phase 1
Completed NCT00581815 - Spectroscopy With Surface Coils and Decoupling Phase 1
Recruiting NCT00006518 - Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer
Completed NCT00001560 - Clinical, Laboratory and Epidemiologic Pilot Studies of Individuals at High Risk for Viral-Associated Cancers N/A
Completed NCT00982449 - 124I-FIAU Imaging in EBV and KSHV Associated Cancers N/A
Recruiting NCT03300830 - Molecular Characterization of Viral-associated Tumors, Tumors Occurring in the Setting of HIV or Other Immune Disorders and Castleman Disease
Completed NCT00006171 - Effects of Potent Antiretroviral Therapy on Kaposi s Sarcoma
Completed NCT02029430 - A Study to Investigate ALDOXORUBICIN in HIV-infected Subjects With Kaposi's Sarcoma Phase 2